REFERENCES
Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., et al., Pharmacol. Rev., 2001, vol. 53, no. 4, pp. 527–552.
Fuxe, K., Ferre, S., Zoli, M., and Agnati, L.F., Brain Res., 1998, vol. 26, pp. 258–273.
Poulsen, S.-A. and Quinn, R.J., Bioorg. Med. Chem.,1998, vol. 6, pp. 619–641.
Gao, Z.-G., Chen, A., Barak, D., et al.,J. Biol. Chem., 2002, vol. 277, pp. 19056–19063.
Kim, J., Wess, J., van Rhee, A.M., et al.,J. Biol. Chem.,1995, vol. 270, pp. 13987–13997.
Olah, M.E., Ren, H., Ostrowski, J., et al.,J. Biol. Chem.,1992, vol. 267, pp. 10764–10770.
Ivanov, A.A., Baskin, I.I., Palyulin, V.A., and Zefirov, N.S.,Dokl. Akad. Nauk, 2002, vol. 386, no. 4, pp. 548–551.
Ivanov, A.A., Baskin, I.I., Palyulin, V.A., and Zefi-rov, N.S.,Mendeleev Commun., 2002, no. 6, pp. 211–212.
Palczewski, K., Kumasaka, T., Hori, T., et al.,Science, 2000, vol. 289, no. 4, pp. 739–745.
Bairoch, A. and Apweiler, R., Nucleic Acids Res., 2000, vol. 28, pp. 45–48.
Sybyl 6.7.2, Tripos, Inc. 1699 South Hanley Road, St. Louis, MO 63144.
Bockaert, J. and Pin, J.P., EMBO J., 1999, vol. 18, no. 7, pp. 1723–1729.
Laskowski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M., J. Appl. Crystallogr., 1993, vol. 26,pp. 283–291.
IJzerman, A.P., van der Wenden, E.M., van Galen, P.J.M., and Jacobson, K.A., Eur. J. Pharmacol.,1994, vol. 268, pp. 95–104.
Jacobson, K.A., Nikodijevic, O., Padgett, W.L., et al., FEBS Lett., 1993, vol. 323, pp. 141–144.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ivanov, A.A., Baskin, I.I., Palyulin, V.A. et al. Molecular Modeling of the Human A2a Adenosine Receptor. Doklady Biochemistry and Biophysics 389, 94–97 (2003). https://doi.org/10.1023/A:1023632005607
Issue Date:
DOI: https://doi.org/10.1023/A:1023632005607